PI(3,5)P 2 controls the signaling activity of class I PI3K
Science Advances · 2026
DOI: 10.1126/sciadv.aeh8582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Jiachen Sun und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Illinois Chicago, Chicago, IL 60607, USA. Hauptthemen laut MEDLINE: Signal Transduction, Phosphatidylinositol Phosphates, Phosphatidylinositol 3-Kinases, Class I Phosphatidylinositol 3-Kinases. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
3-Phosphoinositides are essential cellular lipids regulating health and disease. Among them, phosphatidylinositol-3,5-bisphosphate [PI(3,5)P 2 ] remains the least understood. Using a newly developed ratiometric PI(3,5)P 2 sensor that enables spatiotemporally resolved PI(3,5)P 2 quantification, we demonstrate that growth factor stimulation generates a distinct PI(3,5)P 2 pool on lysosomes and late endosomes. Formed sequentially by class II PI3KC2β and PIKfyve, this PI(3,5)P 2 pool terminates growth factor–stimulated class I phosphatidylinositol 3-kinase (PI3K) activity through a specific interaction with its regulatory p85 subunit. Disrupting this p85-PI(3,5)P 2 interaction via a small-molecule inhibitor or cancer-causing mutations blocks feedback inhibition, driving sustained class I PI3K activation and promoting neurite growth. Our findings uncover a spatiotemporally specific regulatory function of PI(3,5)P 2 that links class I and II PI3Ks to tune growth factor signaling. This mechanism offers therapeutic strategies for treating p85-mutant cancers and advancing tissue regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Illinois Chicago, Chicago, IL 60607, USA.
- Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea.
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
- Department of Biological Sciences, University of Illinois Chicago, Chicago, IL 60607, USA.
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA.
ORCID-Profile: Jiachen Sun, Julian Zalejski, Ashutosh Sharma, Wei Wang, Wen-Ting Lo, Philipp Alexander Koch, Duy-Viet Vo, Jean J Zhao, Ying S Hu, Ruixuan Gao, Wonhwa Cho
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIMH NIH HHS
- National Institutes of Health
- Research Corporation for Science Advancement
- Deutsche Forschungsgemeinschaft
- The European Union
Zitieren
APA
Sun, J., Zalejski, J., Song, S., Sharma, A., Wang, W., Hu, Y., Lo, W. T., Koch, P. A., Vo, D. V., Singh, J., Singaram, I., An, B., Gunasekara, H., Zhao, J. J., Gong, L. W., Hu, Y. S., Haucke, V., Gao, R., & Cho, W. (2026). PI(3,5)P 2 controls the signaling activity of class I PI3K. Science Advances. https://doi.org/10.1126/sciadv.aeh8582
Vancouver
Sun J, Zalejski J, Song S, Sharma A, Wang W, Hu Y, et al. PI(3,5)P 2 controls the signaling activity of class I PI3K. Science Advances. 2026. doi:10.1126/sciadv.aeh8582
BibTeX
@article{Sun2026,
author = {Sun, Jiachen and Zalejski, Julian and Song, Seohyeon and Sharma, Ashutosh and Wang, Wei and Hu, Yusi and Lo, Wen-Ting and Koch, Philipp Alexander and Vo, Duy-Viet and Singh, Jagriti and Singaram, Indira and An, Baoshu and Gunasekara, Hirushi and Zhao, Jean J and Gong, Liang-Wei and Hu, Ying S and Haucke, Volker and Gao, Ruixuan and Cho, Wonhwa},
title = {PI(3,5)P 2 controls the signaling activity of class I PI3K},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeh8582}
}
EUVIMED